Advertisement
Screener

CYPHERPUNK TECHNOLOGIES INC. (CYPH) Pre-Tax Margin

CYPHERPUNK TECHNOLOGIES INC. Pre-Tax Margin

Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • CYPHERPUNK TECHNOLOGIES INC. pre-tax margin for the quarter ending 2021-12-31 was -2883.20%, a change of -1093.33% year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. pre-tax margin for the quarter ending 2021-09-30 was -2970.40%, a change of -1088.53% year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. pre-tax margin for the quarter ending 2021-06-30 was -2540.27%, a change of -802.67% year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. pre-tax margin for the quarter ending 2021-03-31 was -2435.73%, a change of -507.47% year-over-year.
  • CYPHERPUNK TECHNOLOGIES INC. pre-tax margin for fiscal 2021 was -2707.40%, a change of -873.00% from fiscal 2020.
  • CYPHERPUNK TECHNOLOGIES INC. pre-tax margin for fiscal 2020 was -1834.40%.
Available history
2020-03-31 to 2021-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2021-12-31-2883.20%-$10.81M$375,000.00
2021-09-30-2970.40%-$11.14M$375,000.00
2021-06-30-2540.27%-$9.53M$375,000.00
2021-03-31-2435.73%-$9.13M$375,000.00
2020-12-31-1789.87%-$6.71M$375,000.00
2020-09-30-1881.87%-$7.06M$375,000.00
2020-06-30-1737.60%-$6.52M$375,000.00
2020-03-31-1928.27%-$7.23M$375,000.00

Annual Pre-Tax Margin

DatePre-Tax MarginPre-tax incomeRevenue
2021-12-31-2707.40%-$40.61M$1.5M
2020-12-31-1834.40%-$27.52M$1.5M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06